Trial site
NeuroScience Research Center
- 5running trials
- 5closed trials
- 0trials confirmed by the site in the last 60 days
- –languages not stated
The site has not confirmed any trial yet.
Running trials
Recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Researchers
No researcher is linked here yet.
Closed trials
Completed
A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease
Completed
RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
Completed
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
Site data: ClinicalTrials.govUpdated 8 Nov 2026